Raltegravir Kaletra Pharmacokinetics
NCT00564772
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Raltegravir, lopinavir, ritonavir
Sponsor
Allina Health System